329 related articles for article (PubMed ID: 18713246)
21. Turning severe into moderate haemophilia by prophylaxis: are we reaching our goal?
den Uijl I; Biesma D; Grobbee D; Fischer K
Blood Transfus; 2013 Jul; 11(3):364-9. PubMed ID: 23149144
[TBL] [Abstract][Full Text] [Related]
22. Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding rates.
Nijdam A; Foppen W; De Kleijn P; Mauser-Bunschoten EP; Roosendaal G; van Galen KP; Schutgens RE; van der Schouw YT; Fischer K
Thromb Haemost; 2016 May; 115(5):931-8. PubMed ID: 26791021
[TBL] [Abstract][Full Text] [Related]
23. Similar bleeding phenotype in young children with haemophilia A or B: a cohort study.
Clausen N; Petrini P; Claeyssens-Donadel S; Gouw SC; Liesner R;
Haemophilia; 2014 Nov; 20(6):747-55. PubMed ID: 24893572
[TBL] [Abstract][Full Text] [Related]
24. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
Osooli M; Steen Carlsson K; Astermark J; Berntorp E
Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
[TBL] [Abstract][Full Text] [Related]
25. Patterns of tertiary prophylaxis in Canadian adults with severe and moderately severe haemophilia B.
Jackson SC; Yang M; Minuk L; St-Louis J; Sholzberg M; Card R; Iorio A; Poon MC
Haemophilia; 2014 May; 20(3):e199-204. PubMed ID: 24589126
[TBL] [Abstract][Full Text] [Related]
26. Single-dose (270 microg kg(-1)) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.
Pan-Petesch B; Laguna P; Mital A; Stanley J; Torchet MF; Salek SZ; Salaj P
Haemophilia; 2009 May; 15(3):760-5. PubMed ID: 19298382
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors.
Leissinger CA; Becton DL; Ewing NP; Valentino LA
Haemophilia; 2007 May; 13(3):249-55. PubMed ID: 17498073
[TBL] [Abstract][Full Text] [Related]
28. Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States.
Thornburg CD; Carpenter S; Zappa S; Munn J; Leissinger C
Haemophilia; 2012 Jul; 18(4):568-74. PubMed ID: 22335526
[TBL] [Abstract][Full Text] [Related]
29. Haemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data.
Zhou ZY; Wu J; Baker J; Curtis R; Forsberg A; Huszti H; Koerper M; Lou M; Miller R; Parish K; Riske B; Shapiro A; Ullman M; Johnson K
Haemophilia; 2011 Sep; 17(5):729-36. PubMed ID: 21689212
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism in factor VII gene modifies phenotype of severe haemophilia.
Jayandharan GR; Nair SC; Poonnoose PM; Thomas R; John J; Keshav SK; Cherian RS; Devadarishini M; Lakshmi KM; Shaji RV; Viswabandya A; George B; Mathews V; Chandy M; Srivastava A
Haemophilia; 2009 Nov; 15(6):1228-36. PubMed ID: 19686262
[TBL] [Abstract][Full Text] [Related]
31. Joint health and functional ability in children with haemophilia who receive intensive replacement therapy.
Groen W; van der Net J; Bos K; Abad A; Bergstrom BM; Blanchette VS; Feldman BM; Funk S; Helders P; Hilliard P; Manco-Johnson M; Petrini P; Zourikian N; Fischer K
Haemophilia; 2011 Sep; 17(5):783-90. PubMed ID: 21790897
[TBL] [Abstract][Full Text] [Related]
32. Prospective audit of patients with haemophilia: bleeding episodes and management.
Alexander M; Barnes C; Barnett P
J Paediatr Child Health; 2012 Feb; 48(2):177-9. PubMed ID: 21564382
[TBL] [Abstract][Full Text] [Related]
33. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
[TBL] [Abstract][Full Text] [Related]
34. Changing patterns of bleeding in patients with severe haemophilia A.
Stephensen D; Tait RC; Brodie N; Collins P; Cheal R; Keeling D; Melton K; Dolan G; Haye H; Hayman E; Winter M
Haemophilia; 2009 Nov; 15(6):1210-4. PubMed ID: 19659938
[TBL] [Abstract][Full Text] [Related]
35. High incidence of ankle arthropathy in mild and moderate haemophilia A.
Ling M; Heysen JP; Duncan EM; Rodgers SE; Lloyd JV
Thromb Haemost; 2011 Feb; 105(2):261-8. PubMed ID: 21057696
[TBL] [Abstract][Full Text] [Related]
36. Endogenous clotting factor activity and long-term outcome in patients with moderate haemophilia.
Fischer K; van der Bom JG; Mauser-Bunschoten EP; Roosendaal G; Beek FJ; de Kleijn P; Grobbee DE; van den Berg HM
Thromb Haemost; 2000 Dec; 84(6):977-80. PubMed ID: 11154144
[TBL] [Abstract][Full Text] [Related]
37. Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia.
Nijdam A; Foppen W; van der Schouw YT; Mauser-Bunschoten EP; Schutgens RE; Fischer K
Haemophilia; 2016 Nov; 22(6):852-858. PubMed ID: 27396935
[TBL] [Abstract][Full Text] [Related]
38. Variability in clinical phenotype of severe haemophilia: the role of the first joint bleed.
van Dijk K; Fischer K; van der Bom JG; Grobbee DE; van den Berg HM
Haemophilia; 2005 Sep; 11(5):438-43. PubMed ID: 16128885
[TBL] [Abstract][Full Text] [Related]
39. Patient-reported experience of bleeding events in haemophilia.
Flood E; Pocoski J; Michaels LA; McCoy A; Beusterien K; Sasanè R
Eur J Haematol; 2014 Jun; 93 Suppl 75():19-28. PubMed ID: 24966142
[TBL] [Abstract][Full Text] [Related]
40. Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China.
Tang L; Wu R; Sun J; Zhang X; Feng X; Zhang X; Luke KH; Poon MC
Haemophilia; 2013 Jan; 19(1):27-34. PubMed ID: 23231016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
